Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1326
Mama's Creations
MAMA
$639M
| $5.53M | 0.01% |
360,600
+19,300
| +6% | +$293K |
2023 Q2
11 quarters
|
|
1327
SPS Commerce
SPSC
$3.05B
| $5.53M | 0.01% |
+99,360
| New | +$7.16M |
2026 Q1
0 quarters
|
|
1328
PAR Technology
PAR
$642M
| $5.51M | 0.01% |
+413,200
| New | +$9.7M |
2026 Q1
0 quarters
|
|
1329
Black Hills Corp
BKH
$5.8B
| $5.5M | 0.01% |
+79,200
| New | +$5.7M |
2026 Q1
0 quarters
|
|
|
STEL
1330
DELISTED
Stellar Bancorp
STEL
| $5.49M | 0.01% |
+149,986
| New | +$5.38M |
2026 Q1
0 quarters
|
|
1331
Cabaletta Bio
CABA
$327M
| $5.48M | 0.01% |
2,036,663
+514,080
| +34% | +$1.43M |
2024 Q4
5 quarters
|
|
1332
Zimmer Biomet
ZBH
$17B
| $5.47M | 0.01% |
+60,536
| New | +$5.56M |
2026 Q1
0 quarters
|
|
1333
Invesco Mortgage Capital
IVR
$621M
| $5.47M | 0.01% |
677,100
+201,500
| +42% | +$1.72M |
2021 Q4
17 quarters
|
|
|
USAS
1334
Americas Gold and Silver
USAS
$1.47B
| $5.47M | 0.01% |
+1,047,500
| New | +$7.65M |
2026 Q1
0 quarters
|
|
1335
CNB Financial Corp
CCNE
$986M
| $5.46M | 0.01% |
188,445
-26,700
| -12% | -$746K |
2015 Q1
44 quarters
|
|
1336
Emergent Biosolutions
EBS
$362M
| $5.45M | 0.01% |
656,047
+78,900
| +14% | +$817K |
2023 Q4
9 quarters
|
|
1337
Newmark Group
NMRK
$2.2B
| $5.43M | 0.01% |
+362,545
| New | +$5.72M |
2026 Q1
0 quarters
|
|
1338
Talos Energy
TALO
$2.81B
| $5.42M | 0.01% |
344,000
-300,600
| -47% | -$3.86M |
2024 Q3
6 quarters
|
|
1339
4D Molecular Therapeutics
FDMT
$736M
| $5.38M | 0.01% |
578,265
+65,365
| +13% | +$569K |
2025 Q1
4 quarters
|
|
1340
Marcus Corp
MCS
$835M
| $5.37M | 0.01% |
312,970
-102,119
| -25% | -$1.63M |
2021 Q4
17 quarters
|
|
1341
Columbus McKinnon
CMCO
$462M
| $5.37M | 0.01% |
369,323
+258,238
| +232% | +$4.81M |
2025 Q3
2 quarters
|
|
1342
Aptiv
APTV
$9.09B
| $5.35M | 0.01% |
77,000
-128,400
| -63% | -$9.89M |
2025 Q4
1 quarter
|
|
|
LAR
1343
Lithium Argentina AG
LAR
$865M
| $5.33M | 0.01% |
+797,600
| New | +$5.71M |
2026 Q1
0 quarters
|
|
1344
Riskified
RSKD
$1.13B
| $5.33M | 0.01% |
1,358,900
+22,100
| +2% | +$97.9K |
2021 Q4
17 quarters
|
|
1345
Babcock & Wilcox
BW
$813M
| $5.33M | 0.01% |
362,500
+17,000
| +5% | +$179K |
2025 Q3
2 quarters
|
|
|
JBTM
1346
JBT Marel
JBTM
$5.55B
| $5.31M | 0.01% |
41,500
-75,200
| -64% | -$11.4M |
2025 Q1
4 quarters
|
|
1347
iShares Russell Top 200 Growth ETF
IWY
$16.7B
| $5.3M | 0.01% |
21,280
+20,440
| +2,433% | +$5.42M |
2025 Q3
2 quarters
|
|
1348
HUB Group
HUBG
$1.58B
| $5.29M | 0.01% |
146,672
+139,900
| +2,066% | +$5.91M |
2025 Q2
3 quarters
|
|
1349
Pangaea Logistics
PANL
$545M
| $5.28M | 0.01% |
746,100
+185,100
| +33% | +$1.46M |
2021 Q1
20 quarters
|
|
1350
AbCellera Biologics
ABCL
$4.06B
| $5.27M | 0.01% |
1,510,629
-878,600
| -37% | -$3.16M |
2021 Q2
19 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.